Overcoming disease refractoriness through CD7-targeting CAR T cells in acute myeloid leukemia
Molecular Therapy Oncology · 2026-06 · 34 (2) · 201208
DOI: 10.1016/j.omton.2026.201208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy Oncology, 2026-06. Verfasst von Marco Becilli und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Bambin…. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Over the last decade, CD19-targeting chimeric antigen receptor (CAR) T cell therapy has emerged as a major breakthrough in the treatment of B-cell malignancies, leading to significantly improved outcomes in both children and adults with relapsed/refractory (R/R) acute lymphoblastic leukemia.1 However, replicating these results in the setting of acute myeloid leukemia (AML), refractory or relapsing after conventional or even innovative approaches, has proven challenging. For patients with R/R AML, outcomes remain dismal, and allogeneic hematopoietic stem cell transplantation (HSCT) represents the only potentially curative option, provided that a new complete remission is achieved, ideally with measurable residual disease (MRD) negativity.
Autor:innen und Institutionen
- Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Bambino Gesù Children's Hospital, Rome, Italy.
- Department of Life Sciences and Public Health, Catholic University of the Sacred Heart, Rome, Italy.
Zitieren
APA
Becilli, M., & Locatelli, F. (2026). Overcoming disease refractoriness through CD7-targeting CAR T cells in acute myeloid leukemia. Molecular Therapy Oncology, 34(2), 201208. https://doi.org/10.1016/j.omton.2026.201208
Vancouver
Becilli M, Locatelli F. Overcoming disease refractoriness through CD7-targeting CAR T cells in acute myeloid leukemia. Molecular Therapy Oncology. 2026;34(2):201208. doi:10.1016/j.omton.2026.201208
BibTeX
@article{Becilli2026,
author = {Becilli, Marco and Locatelli, Franco},
title = {Overcoming disease refractoriness through CD7-targeting CAR T cells in acute myeloid leukemia},
journal = {Molecular Therapy Oncology},
year = {2026},
volume = {34},
number = {2},
pages = {201208},
doi = {10.1016/j.omton.2026.201208}
}
EUVIMED